OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Use of thiopurines in inflammatory bowel disease: an update
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, et al.
Intestinal Research (2021) Vol. 20, Iss. 1, pp. 11-30
Open Access | Times Cited: 71
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, et al.
Intestinal Research (2021) Vol. 20, Iss. 1, pp. 11-30
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
Tofacitinib in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial
Arshdeep Singh, Manjeet Kumar Goyal, Vandana Midha, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 7, pp. 1365-1372
Closed Access | Times Cited: 44
Arshdeep Singh, Manjeet Kumar Goyal, Vandana Midha, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 7, pp. 1365-1372
Closed Access | Times Cited: 44
Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis
Apurva Jadhav, Suresh Jagtap, Suresh Vyavahare, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 24
Apurva Jadhav, Suresh Jagtap, Suresh Vyavahare, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 24
Ulcerative colitis: molecular insights and intervention therapy
Yuqing Liang, Yang Li, Chehao Lee, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Yuqing Liang, Yang Li, Chehao Lee, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study
Abhirup Chatterjee, Prateek Bhatia, Saroj K. Sinha, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access | Times Cited: 1
Abhirup Chatterjee, Prateek Bhatia, Saroj K. Sinha, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access | Times Cited: 1
Thiopurine S-methyltransferase – An important intersection of drug-drug interactions in thiopurine treatment
Dunja Urbančič, Marko Jukič, Alenka Šmid, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117893-117893
Open Access | Times Cited: 1
Dunja Urbančič, Marko Jukič, Alenka Šmid, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117893-117893
Open Access | Times Cited: 1
Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study
Arshdeep Singh, Vandana Midha, Kirandeep Kaur, et al.
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 2, pp. 300-307
Closed Access | Times Cited: 19
Arshdeep Singh, Vandana Midha, Kirandeep Kaur, et al.
Journal of Crohn s and Colitis (2023) Vol. 18, Iss. 2, pp. 300-307
Closed Access | Times Cited: 19
Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care
Ahmed B. Bayoumy, Chris J. Mulder, Azhar Ansari, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 36-47
Open Access | Times Cited: 6
Ahmed B. Bayoumy, Chris J. Mulder, Azhar Ansari, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 36-47
Open Access | Times Cited: 6
Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
Jihye Park, Jae Hee Cheon
The Korean Journal of Internal Medicine (2022) Vol. 37, Iss. 5, pp. 895-905
Open Access | Times Cited: 20
Jihye Park, Jae Hee Cheon
The Korean Journal of Internal Medicine (2022) Vol. 37, Iss. 5, pp. 895-905
Open Access | Times Cited: 20
Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
Rohan V Yewale, Banumathi Ramakrishna, Babu Vinish Doraisamy, et al.
JGH Open (2023) Vol. 7, Iss. 9, pp. 599-609
Open Access | Times Cited: 12
Rohan V Yewale, Banumathi Ramakrishna, Babu Vinish Doraisamy, et al.
JGH Open (2023) Vol. 7, Iss. 9, pp. 599-609
Open Access | Times Cited: 12
Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
June Hwa Bae, Jung-Bin Park, Ji Eun Baek, et al.
Gut and Liver (2024) Vol. 18, Iss. 4, pp. 667-676
Open Access | Times Cited: 4
June Hwa Bae, Jung-Bin Park, Ji Eun Baek, et al.
Gut and Liver (2024) Vol. 18, Iss. 4, pp. 667-676
Open Access | Times Cited: 4
Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease
Tracy Coelho, Guo Cheng, Sophie Lewis, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 4
Tracy Coelho, Guo Cheng, Sophie Lewis, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 4
Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases
Aleksandra Strigáč, M Caban, Ewa Małecka‐Panas, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4678-4678
Open Access | Times Cited: 4
Aleksandra Strigáč, M Caban, Ewa Małecka‐Panas, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4678-4678
Open Access | Times Cited: 4
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Ainsworth, et al.
Drugs (2024)
Closed Access | Times Cited: 4
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Ainsworth, et al.
Drugs (2024)
Closed Access | Times Cited: 4
Comparison of Effects on 6-Thioguanine Nucleotides According to Mesalazine Formulation in Pediatric Patients with Ulcerative Colitis
Hansol Kim, Yoon Zi Kim, Seon Young Kim, et al.
Clinical Therapeutics (2025)
Closed Access
Hansol Kim, Yoon Zi Kim, Seon Young Kim, et al.
Clinical Therapeutics (2025)
Closed Access
Thiopurine S-Methyltransferase Genotype Mutation in Pediatric Patients with Inflammatory Bowel Disease on Azathioprine: A Pilot Study
Mostafa Abdel-Aziz El-Hodhod, Marwa Talaat El-Deeb, Yosra Mohamed Mohsen, et al.
Acta Scientific Medical Sciences (2025), pp. 03-10
Open Access
Mostafa Abdel-Aziz El-Hodhod, Marwa Talaat El-Deeb, Yosra Mohamed Mohsen, et al.
Acta Scientific Medical Sciences (2025), pp. 03-10
Open Access
Medical Management of Ulcerative Colitis and Crohn’s Disease—Strategies for Inducing and Maintaining Remission
Mohamed Tausif Siddiqui, Rhytha Kasiraj, Maliha Naseer
Surgical Clinics of North America (2025) Vol. 105, Iss. 2, pp. 435-454
Closed Access
Mohamed Tausif Siddiqui, Rhytha Kasiraj, Maliha Naseer
Surgical Clinics of North America (2025) Vol. 105, Iss. 2, pp. 435-454
Closed Access
Cutting Edge: A Comprehensive Guide to Colorectal Cancer Surgery in Inflammatory Bowel Diseases
Ionuț Eduard Iordache, Lucian-Flavius Herlo, R. Popescu, et al.
Journal of Mind and Medical Sciences (2025) Vol. 12, Iss. 1, pp. 6-6
Open Access
Ionuț Eduard Iordache, Lucian-Flavius Herlo, R. Popescu, et al.
Journal of Mind and Medical Sciences (2025) Vol. 12, Iss. 1, pp. 6-6
Open Access
Perspectives in clinical research on Azathioprine for steroid-dependent ulcerative colitis
Yingli Qu, Jianqing Ding, Pan W, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Yingli Qu, Jianqing Ding, Pan W, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease: Observations From Daily Practice
Mila Lovrić, Kristina Dukić, Silvija Čuković‐Čavka, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
Mila Lovrić, Kristina Dukić, Silvija Čuković‐Čavka, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies
Stefan Schreiber, Jean‐Frédéric Colombel, Stephen B. Hanauer, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
Stefan Schreiber, Jean‐Frédéric Colombel, Stephen B. Hanauer, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
NDP52 and its emerging role in pathogenesis
Krenare Bruqi, Flavie Strappazzon
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Krenare Bruqi, Flavie Strappazzon
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?
Walter Fries, Maria Giulia Demarzo, Giuseppe Navarra, et al.
Drugs & Aging (2022) Vol. 39, Iss. 6, pp. 441-452
Open Access | Times Cited: 16
Walter Fries, Maria Giulia Demarzo, Giuseppe Navarra, et al.
Drugs & Aging (2022) Vol. 39, Iss. 6, pp. 441-452
Open Access | Times Cited: 16
Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo
Alexander K. B. Turbayne, Miles Sparrow
Digestive Diseases and Sciences (2022) Vol. 67, Iss. 12, pp. 5382-5391
Open Access | Times Cited: 16
Alexander K. B. Turbayne, Miles Sparrow
Digestive Diseases and Sciences (2022) Vol. 67, Iss. 12, pp. 5382-5391
Open Access | Times Cited: 16
Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing
Ralley Prentice, Emma Flanagan, Emily K. Wright, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 7, pp. 1081-1090
Closed Access | Times Cited: 3
Ralley Prentice, Emma Flanagan, Emily K. Wright, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 7, pp. 1081-1090
Closed Access | Times Cited: 3
Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 507-507
Open Access | Times Cited: 13
Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 507-507
Open Access | Times Cited: 13
